| GYRE YTD Return Table | ||||||||||||||||||||||||||||||
GYRE YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Use our YTD Return Calculator to
compare GYRE YTD return versus benchmarks: YTD Return for S&P YTD Return for Dow YTD Return for Nasdaq 100 YTD Return for Russell 2000 YTD Return for Gold YTD Return for 10 Year Treasury |
| GYRE Share Performance |
| GYRE YTD Return Chart | |||
Also see: GYRE Average Annual Return | |||
| About Gyre Therapeutics Inc |
| Gyre Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is engaged in the research, development, manufacturing, and commercialization of drugs for organ fibrosis. It is primarily focused on the development and commercialization of F351 (Hydronidone) for the treatment of Nonalcoholic Steatohepatitis Treatment (NASH)-associated fibrosis. Co. is also advancing a diverse pipeline in the China through its indirect controlling interest in Gyre Pharmaceuticals, including ETUARY therapeutic expansions, F573, F528, and F230. Co. operates through two segments: Gyre Pharmaceuticals, and Gyre after the Contributions. The GYRE YTD return is shown above.
The YTD Return on the GYRE YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether GYRE YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the GYRE YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| GYRE Current Stock Quote |
Quotes delayed 20 minutes  Free GYRE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Gyre Therapeutics (GYRE) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
HAE YTD Return HAIR YTD Return HALO YTD Return HARP YTD Return HBIO YTD Return HCA YTD Return HCWB YTD Return HEPA YTD Return HGEN YTD Return HILS YTD Return More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.
Video: Don't Forget Dividends in YTD Return!